Circulating Chromogranin A as a Surveillance Biomarker in Patients with Carcinoids-The CASPAR Study
{{output}}
Purpose: Gastroenteropancreatic neuroendocrine tumors (GEP-NET) are relatively indolent but can be more aggressive. The current recommendations for using serum chromogranin A (CgA) for patients with GEP-NET are equivocal. This st... ...
